Article Text


916 Evaluation of a multidisciplinary cancer clinic: improving time to oncology assessment and treatment for patients with new lung cancer
  1. Christopher Stone1,
  2. Erin Brown2,
  3. Mihaela Mates1,
  4. Conrad Falkson1,
  5. Timothy Owen1,
  6. Allison Ashworth1,
  7. Aamer Mahmud1,
  8. Christopher Parker1,
  9. Andrew Robinson1,
  10. Genevieve Digby1
  1. 1Kingston Health Science Centre and Queen’s University, Canada
  2. 2South East Regional Cancer Program, Canada


Background Delays in the management of lung cancer (LC) are associated with inferior outcomes. Multidisciplinary cancer clinics (MDCC) can improve timeliness and quality of care.

Objectives Decrease time from LC diagnosis to oncology assessment from 13 to 3 days, and to treatment from 30 to <20 days, within 6 months.

Methods We implemented a weekly MDCC, involving Respirologists, Medical Oncologists (MO) and Radiation Oncologists (RO), where patients with new LC diagnoses received concurrent oncology consultation. We retrospectively analysed data pre-MDCC (November 2016 – February 2017) and prospectively for improvements (February – July 2017). Improvement cycles included MDCC clinic launching and a debriefing/troubleshooting meeting. Data are reported as n(%), and means as per Statistical Process Control XmR(i) charts.

Results 117 patients (44 pre-MDCC, 73 post-MDCC) were analysed. Most patients had stage 4 (44, 37.6%) or stage 1 LC (32, 27%). All patients saw Respirology, in addition to MO (85, 72.6%), RO (113, 96.6%), or both (83, 71.0%). The proportion of treated patients was unchanged pre- vs. post-MDCC (88.6%, 85.4%). Mean days from diagnosis to oncology assessment decreased from 14.3 to 5.0 days. Time from diagnosis to first treatment decreased from 39.8 to 27.2 days after the first improvement cycle, and to 18.1 days after the second improvement cycle (Figure 1), with less variation in time to treatment after improvement events.

Abstract 916 Figure 1

Effect of MDCC on time from lung cancer diagnosis to first cancer treatment

Conclusions MDCC shortens time from LC diagnosis to oncology assessment and treatment. Time to treatment improved more than time to oncology assessment, suggesting the improvement is likely related to benefits beyond just faster oncology assessment.

Statistics from

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.